Consistently, we reported here a concomitant overall (i) increase in phosphorylated eIF2α protein levels and (ii) reduction in SMAD2/3 and SMAD4 nuclear protein levels in HF-treated mice. The gene discussed is SMAD4; the disease is hydrops fetalis.